Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
Rheumatology (Oxford, England)|February 24, 2009
Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohortMaria I Danila, Guillermo J Pons-Estel, Jie Zhang, et al.
Therapeutic Advances in Musculoskeletal Disease|March 28, 2022
Osteoporosis in 10 years time: a glimpse into the future of osteoporosisGiovanni Adami, Angelo Fassio, Davide Gatti, et al.
Human Molecular Genetics|August 4, 2022
A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South AfricaEvans M Mathebula, Dhriti Sengupta, Nimmisha Govind, et al.
Annals of the New York Academy of Sciences|May 3, 2003
Molecular mechanism of serial VH gene replacementZhixin Zhang, Yui-Hsi Wang, Michael Zemlin, et al.
Blood|October 24, 2002
V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiationYui-Hsi Wang, Zhixin Zhang, Peter D Burrows, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 15, 2019
Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosisRuchi Yadav, Dae-Goon Yoo, J Michelle Kahlenberg, et al.
Immunogenetics|February 12, 2014
CASPASE-12 and rheumatoid arthritis in African-AmericansLaura Marshall, Mohammad Obaidullah, Trista Fuchs, et al.
Elife|May 16, 2019
IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiationEsther Zumaquero, Sara L Stone, Christopher D Scharer, et al.
Journal of Psoriasis and Psoriatic Arthritis|February 10, 2018
Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic AgentsJeffrey R Curtis, Maria I Danila, Lang Chen, et al.
Pageof 21